Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study

OBJECTIVES: We estimated vaccine effectiveness (VE) of primary and booster vaccinations against SARS-CoV-2 infection overall and in four risk groups defined by age and medical risk condition during the Delta and Omicron BA.1/BA.2 periods. METHODS: VAccine Study COvid-19 is an ongoing prospective coh...

Descripción completa

Detalles Bibliográficos
Autores principales: Huiberts, Anne J., de Gier, Brechje, Hoeve, Christina E., de Melker, Hester E., Hahné, Susan J.M., den Hartog, Gerco, Grobbee, Diederick E., van de Wijgert, Janneke H.H.M., van den Hof, Susan, Knol, Mirjam J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118053/
https://www.ncbi.nlm.nih.gov/pubmed/37086863
http://dx.doi.org/10.1016/j.ijid.2023.04.401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118053/
https://www.ncbi.nlm.nih.gov/pubmed/37086863
http://dx.doi.org/10.1016/j.ijid.2023.04.401

Ejemplares similares